 | • レポートコード：MRC2012A1357 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオ医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオ医薬品の種類別市場規模（フミラ、レミケード、リツキサン、エンブレル、ランタス、アバスチン、ハーセプチン、その他）、用途別市場規模（糖尿病、炎症、自己免疫疾患、血液疾患、循環器疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Novartis、Merck & Co.、Abbott Laboratories、Sanofi、Johnson & Johnson、Amgen、Amgen、Pfizer、Eli Lilly、 ・地域別グローバル市場分析 2015年-2020年 ・バイオ医薬品の北米市場（アメリカ、カナダ、メキシコ） ・バイオ医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオ医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオ医薬品の南米市場（ブラジル、アルゼンチン） ・バイオ医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：フミラ、レミケード、リツキサン、エンブレル、ランタス、アバスチン、ハーセプチン、その他 ・用途別分析：糖尿病、炎症、自己免疫疾患、血液疾患、循環器疾患、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Biologic Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Biologic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biologic Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biologic Drugs market has been segmented into
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
By Application, Biologic Drugs has been segmented into:
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biologic Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Biologic Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biologic Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Biologic Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Biologic Drugs Market Share Analysis
Biologic Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biologic Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biologic Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Biologic Drugs are:
Roche
Novartis
Merck & Co.
Abbott Laboratories
Sanofi
Johnson & Johnson
Amgen
Amgen
Pfizer
Eli Lilly
Among other players domestic and global, Biologic Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biologic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biologic Drugs, with price, sales, revenue and global market share of Biologic Drugs in 2018 and 2019.
Chapter 3, the Biologic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biologic Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biologic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Biologic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biologic Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Humira
1.2.3 Remicade
1.2.4 Rituxan
1.2.5 Enbrel
1.2.6 Lantus
1.2.7 Avastin
1.2.8 Herceptin
1.2.9 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Biologic Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diabetes
1.3.3 Inflammation
1.3.4 Auto-Immune Diseases
1.3.5 Blood Diseases
1.3.6 Cardiovascular Diseases
1.3.7 Others
1.4 Overview of Global Biologic Drugs Market
1.4.1 Global Biologic Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck & Co.
2.3.1 Merck & Co. Details
2.3.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck & Co. SWOT Analysis
2.3.4 Merck & Co. Product and Services
2.3.5 Merck & Co. Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott Laboratories SWOT Analysis
2.4.4 Abbott Laboratories Product and Services
2.4.5 Abbott Laboratories Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amgen SWOT Analysis
2.7.4 Amgen Product and Services
2.7.5 Amgen Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen SWOT Analysis
2.8.4 Amgen Product and Services
2.8.5 Amgen Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Eli Lilly SWOT Analysis
2.10.4 Eli Lilly Product and Services
2.10.5 Eli Lilly Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biologic Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biologic Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biologic Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Biologic Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biologic Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Biologic Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biologic Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Biologic Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Biologic Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biologic Drugs Sales and Growth Rate (2015-2020)
4.5 South America Biologic Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biologic Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biologic Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Biologic Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Biologic Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Biologic Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Biologic Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Biologic Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biologic Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Biologic Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biologic Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Biologic Drugs Sales and Growth Rate (2015-2020)
6.3 UK Biologic Drugs Sales and Growth Rate (2015-2020)
6.4 France Biologic Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Biologic Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Biologic Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biologic Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biologic Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biologic Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Biologic Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Biologic Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Biologic Drugs Sales and Growth Rate (2015-2020)
7.5 India Biologic Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biologic Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Biologic Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biologic Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Biologic Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Biologic Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biologic Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Biologic Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biologic Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biologic Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biologic Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biologic Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Biologic Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Biologic Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Biologic Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biologic Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Biologic Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Biologic Drugs Price by Type (2015-2020)
11 Global Biologic Drugs Market Segment by Application
11.1 Global Biologic Drugs Sales Market Share by Application (2015-2020)
11.2 Global Biologic Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Biologic Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biologic Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Biologic Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Biologic Drugs Market Forecast (2021-2025)
12.2.2 Europe Biologic Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biologic Drugs Market Forecast (2021-2025)
12.2.4 South America Biologic Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biologic Drugs Market Forecast (2021-2025)
12.3 Biologic Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Biologic Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Biologic Drugs Market Share Forecast by Type (2021-2025)
12.4 Biologic Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Biologic Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Biologic Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Biologic Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biologic Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biologic Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Biologic Drugs Major Business
Table 9. Roche Biologic Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Roche SWOT Analysis
Table 11. Roche Biologic Drugs Product and Services
Table 12. Roche Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Biologic Drugs Major Business
Table 15. Novartis Biologic Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Novartis SWOT Analysis
Table 17. Novartis Biologic Drugs Product and Services
Table 18. Novartis Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 20. Merck & Co. Biologic Drugs Major Business
Table 21. Merck & Co. Biologic Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Merck & Co. SWOT Analysis
Table 23. Merck & Co. Biologic Drugs Product and Services
Table 24. Merck & Co. Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 26. Abbott Laboratories Biologic Drugs Major Business
Table 27. Abbott Laboratories Biologic Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Abbott Laboratories SWOT Analysis
Table 29. Abbott Laboratories Biologic Drugs Product and Services
Table 30. Abbott Laboratories Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Biologic Drugs Major Business
Table 33. Sanofi Biologic Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Sanofi SWOT Analysis
Table 35. Sanofi Biologic Drugs Product and Services
Table 36. Sanofi Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 38. Johnson & Johnson Biologic Drugs Major Business
Table 39. Johnson & Johnson Biologic Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Johnson & Johnson SWOT Analysis
Table 41. Johnson & Johnson Biologic Drugs Product and Services
Table 42. Johnson & Johnson Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Amgen Basic Information, Manufacturing Base and Competitors
Table 44. Amgen Biologic Drugs Major Business
Table 45. Amgen Biologic Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Amgen SWOT Analysis
Table 47. Amgen Biologic Drugs Product and Services
Table 48. Amgen Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Amgen Basic Information, Manufacturing Base and Competitors
Table 50. Amgen Biologic Drugs Major Business
Table 51. Amgen Biologic Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Amgen SWOT Analysis
Table 53. Amgen Biologic Drugs Product and Services
Table 54. Amgen Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Pfizer Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Biologic Drugs Major Business
Table 57. Pfizer Biologic Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Pfizer SWOT Analysis
Table 59. Pfizer Biologic Drugs Product and Services
Table 60. Pfizer Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 62. Eli Lilly Biologic Drugs Major Business
Table 63. Eli Lilly Biologic Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Eli Lilly SWOT Analysis
Table 65. Eli Lilly Biologic Drugs Product and Services
Table 66. Eli Lilly Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Biologic Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Biologic Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Biologic Drugs Sales by Regions (2015-2020) (K Units)
Table 70. Global Biologic Drugs Sales Market Share by Regions (2015-2020)
Table 71. Global Biologic Drugs Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Biologic Drugs Sales by Countries (2015-2020) (K Units)
Table 73. North America Biologic Drugs Sales Market Share by Countries (2015-2020)
Table 74. North America Biologic Drugs Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Biologic Drugs Revenue Market Share by Countries (2015-2020)
Table 76. Europe Biologic Drugs Sales by Countries (2015-2020) (K Units)
Table 77. Europe Biologic Drugs Sales Market Share by Countries (2015-2020)
Table 78. Europe Biologic Drugs Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Biologic Drugs Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Biologic Drugs Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Biologic Drugs Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Biologic Drugs Sales by Countries (2015-2020) (K Units)
Table 83. South America Biologic Drugs Sales Market Share by Countries (2015-2020)
Table 84. South America Biologic Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Biologic Drugs Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Biologic Drugs Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Biologic Drugs Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Biologic Drugs Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Biologic Drugs Revenue Market Share by Countries (2015-2020)
Table 90. Global Biologic Drugs Sales by Type (2015-2020) (K Units)
Table 91. Global Biologic Drugs Sales Share by Type (2015-2020)
Table 92. Global Biologic Drugs Revenue by Type (2015-2020) (USD Million)
Table 93. Global Biologic Drugs Revenue Share by Type (2015-2020)
Table 94. Global Biologic Drugs Sales by Application (2015-2020) (K Units)
Table 95. Global Biologic Drugs Sales Share by Application (2015-2020)
Table 96. Global Biologic Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Biologic Drugs Market Share Forecast by Regions (2021-2025)
Table 98. Global Biologic Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Biologic Drugs Market Share Forecast by Type (2021-2025)
Table 100. Global Biologic Drugs Sales Forecast by Application (2021-2025)
Table 101. Global Biologic Drugs Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Biologic Drugs Picture
Figure 2. Global Sales Market Share of Biologic Drugs by Type in 2019
Figure 3. Humira Picture
Figure 4. Remicade Picture
Figure 5. Rituxan Picture
Figure 6. Enbrel Picture
Figure 7. Lantus Picture
Figure 8. Avastin Picture
Figure 9. Herceptin Picture
Figure 10. Others Picture
Figure 11. Biologic Drugs Sales Market Share by Application in 2018
Figure 12. Diabetes Picture
Figure 13. Inflammation Picture
Figure 14. Auto-Immune Diseases Picture
Figure 15. Blood Diseases Picture
Figure 16. Cardiovascular Diseases Picture
Figure 17. Others Picture
Figure 18. Global Biologic Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 19. United States Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Canada Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Mexico Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Germany Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. France Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. UK Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Russia Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Italy Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. China Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Japan Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Korea Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. India Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Southeast Asia Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Australia Biologic Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 33. Brazil Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Egypt Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Saudi Arabia Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 36. South Africa Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 37. Turkey Biologic Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 38. Global Biologic Drugs Sales Market Share by Manufacturer in 2019
Figure 39. Global Biologic Drugs Revenue Market Share by Manufacturer in 2019
Figure 40. Top 3 Biologic Drugs Manufacturer (Revenue) Market Share in 2019
Figure 41. Top 6 Biologic Drugs Manufacturer (Revenue) Market Share in 2019
Figure 42. Key Manufacturer Market Share Trend
Figure 43. Global Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 44. Global Biologic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. Global Biologic Drugs Revenue Market Share by Regions (2015-2020)
Figure 46. Global Biologic Drugs Revenue Market Share by Regions in 2018
Figure 47. North America Biologic Drugs Sales and Growth Rate (2015-2020)
Figure 48. Europe Biologic Drugs Sales and Growth Rate (2015-2020)
Figure 49. Asia-Pacific Biologic Drugs Sales and Growth Rate (2015-2020)
Figure 50. South America Biologic Drugs Sales and Growth Rate (2015-2020)
Figure 51. Middle East & Africa Biologic Drugs Sales and Growth Rate (2015-2020)
Figure 52. North America Biologic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. North America Biologic Drugs Sales Market Share by Countries (2015-2020)
Figure 54. North America Biologic Drugs Sales Market Share by Countries in 2018
Figure 55. North America Biologic Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 56. North America Biologic Drugs Revenue Market Share by Countries in 2018
Figure 57. United States Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Canada Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Mexico Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Europe Biologic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Europe Biologic Drugs Revenue Market Share by Countries (2015-2020)
Figure 62. Europe Biologic Drugs Revenue Market Share by Countries in 2019
Figure 63. Germany Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. UK Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. France Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Russia Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Italy Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Asia-Pacific Biologic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. Asia-Pacific Biologic Drugs Sales Market Share by Regions 2019
Figure 70. Asia-Pacific Biologic Drugs Revenue Market Share by Regions 2019
Figure 71. China Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Japan Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Korea Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. India Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Southeast Asia Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. South America Biologic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. South America Biologic Drugs Sales Market Share by Countries in 2019
Figure 78. South America Biologic Drugs Revenue Market Share by Countries in 2019
Figure 79. Brazil Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Argentina Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Middle East and Africa Biologic Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 82. Middle East and Africa Biologic Drugs Sales Market Share by Countries in 2019
Figure 83. Middle East and Africa Biologic Drugs Revenue Market Share by Countries (2015-2020)
Figure 84. Middle East and Africa Biologic Drugs Revenue Market Share by Countries in 2019
Figure 85. Saudi Arabia Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 86. Egypt Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 87. Turkey Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 88. South Africa Biologic Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 89. Global Biologic Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 90. Global Biologic Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 91. North America Sales Biologic Drugs Market Forecast (2021-2025) (K Units)
Figure 92. Europe Sales Biologic Drugs Market Forecast (2021-2025) (K Units)
Figure 93. Asia-Pacific Sales Biologic Drugs Market Forecast (2021-2025) (K Units)
Figure 94. South America Sales Biologic Drugs Market Forecast (2021-2025) (K Units)
Figure 95. Middle East & Africa Sales Biologic Drugs Market Forecast (2021-2025) (K Units)
Figure 96. Sales Channel: Direct Channel vs Indirect Channel
生物学的薬剤の世界市場（～2026年） Market Analysis and Insights: Global Biologic Drugs Market The global Biologic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Biologic Drugs Scope and Market Size Biologic Drugs market is segmented by Type, and …- コレステロール低下生物学的薬剤の世界市場（～2026年） The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments. The old method of treating cholesterol elevated levels includes a change in diet and consuming statin pills to prevent the body from making more bad chol…
- 生物学的治療薬の世界市場（～2026年） Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural s…
- 生物学的治療の世界市場（～2026年） Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural s…
- 中枢神経系疾患治療薬の世界市場（～2026年） A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous system Market Analysis and Insights: Global Drugs for Central Nervous System Diseases Market The global Drugs for Central Nervous System Diseases market size is projected to reac…